COVID-19 Impact on Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2020-2026
This report focuses on the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Furiex Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Melinta Therapeutics, Inc.
- Debiopharm International S.A.
- MerLion Pharmaceuticals Pte Ltd.
- Durata Therapeutics, Inc.
- Paratek Pharmaceuticals, Inc.
- Cempra, Inc.
- Abbott Laboratories, Inc.
- Actelion Pharmaceuticals Ltd.
- Albany Molecular Research, Inc.
- Allergan plc.
- AstraZeneca
- Bayer AG
- Macrolide Pharmaceuticals, Inc.
- Merck & Co, Inc.
- Pfizer, Inc.
- Sanofi
- Teva Pharmaceuticals Industries Ltd.
- Zavante Therapeutics, Inc.
- Delafloxacin
- Vancomycin
- Ceftaroline Fosamil
- Others
- Cellulitis
- Abscess
- Surgical Wounds
- Traumatic Wound
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment status, future forecast, growth opportunity, key market and key players.
- To present the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Delafloxacin
1.4.3 Vancomycin
1.4.4 Ceftaroline Fosamil
1.4.5 Others
1.5 Market by Application
1.5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Cellulitis
1.5.3 Abscess
1.5.4 Surgical Wounds
1.5.5 Traumatic Wound
1.6 Coronavirus Disease 2019 (Covid-19): Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry
1.6.1.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Perspective (2015-2026)
2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Regions
2.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Market Size
3.1.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue (2015-2020)
3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio
3.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2019
3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players Head office and Area Served
3.4 Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
3.5 Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2021-2026)
5 ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in North America (2019-2020)
6.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
6.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in China (2019-2020)
8.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
8.4 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in India (2019-2020)
11.3 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
11.4 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
12.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Furiex Pharmaceuticals, Inc.
13.1.1 Furiex Pharmaceuticals, Inc. Company Details
13.1.2 Furiex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020))
13.1.5 Furiex Pharmaceuticals, Inc. Recent Development
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Details
13.2.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
13.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline plc Recent Development
13.3 Melinta Therapeutics, Inc.
13.3.1 Melinta Therapeutics, Inc. Company Details
13.3.2 Melinta Therapeutics, Inc. Business Overview and Its Total Revenue
13.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.3.5 Melinta Therapeutics, Inc. Recent Development
13.4 Debiopharm International S.A.
13.4.1 Debiopharm International S.A. Company Details
13.4.2 Debiopharm International S.A. Business Overview and Its Total Revenue
13.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.4.5 Debiopharm International S.A. Recent Development
13.5 MerLion Pharmaceuticals Pte Ltd.
13.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details
13.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview and Its Total Revenue
13.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
13.6 Durata Therapeutics, Inc.
13.6.1 Durata Therapeutics, Inc. Company Details
13.6.2 Durata Therapeutics, Inc. Business Overview and Its Total Revenue
13.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.6.5 Durata Therapeutics, Inc. Recent Development
13.7 Paratek Pharmaceuticals, Inc.
13.7.1 Paratek Pharmaceuticals, Inc. Company Details
13.7.2 Paratek Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.7.5 Paratek Pharmaceuticals, Inc. Recent Development
13.8 Cempra, Inc.
13.8.1 Cempra, Inc. Company Details
13.8.2 Cempra, Inc. Business Overview and Its Total Revenue
13.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.8.5 Cempra, Inc. Recent Development
13.9 Abbott Laboratories, Inc.
13.9.1 Abbott Laboratories, Inc. Company Details
13.9.2 Abbott Laboratories, Inc. Business Overview and Its Total Revenue
13.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.9.5 Abbott Laboratories, Inc. Recent Development
13.10 Actelion Pharmaceuticals Ltd.
13.10.1 Actelion Pharmaceuticals Ltd. Company Details
13.10.2 Actelion Pharmaceuticals Ltd. Business Overview and Its Total Revenue
13.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.10.5 Actelion Pharmaceuticals Ltd. Recent Development
13.11 Albany Molecular Research, Inc.
10.11.1 Albany Molecular Research, Inc. Company Details
10.11.2 Albany Molecular Research, Inc. Business Overview and Its Total Revenue
10.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.11.5 Albany Molecular Research, Inc. Recent Development
13.12 Allergan plc.
10.12.1 Allergan plc. Company Details
10.12.2 Allergan plc. Business Overview and Its Total Revenue
10.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.12.5 Allergan plc. Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview and Its Total Revenue
10.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 Bayer AG
10.14.1 Bayer AG Company Details
10.14.2 Bayer AG Business Overview and Its Total Revenue
10.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.14.5 Bayer AG Recent Development
13.15 Macrolide Pharmaceuticals, Inc.
10.15.1 Macrolide Pharmaceuticals, Inc. Company Details
10.15.2 Macrolide Pharmaceuticals, Inc. Business Overview and Its Total Revenue
10.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.15.5 Macrolide Pharmaceuticals, Inc. Recent Development
13.16 Merck & Co, Inc.
10.16.1 Merck & Co, Inc. Company Details
10.16.2 Merck & Co, Inc. Business Overview and Its Total Revenue
10.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.16.5 Merck & Co, Inc. Recent Development
13.17 Pfizer, Inc.
10.17.1 Pfizer, Inc. Company Details
10.17.2 Pfizer, Inc. Business Overview and Its Total Revenue
10.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.17.5 Pfizer, Inc. Recent Development
13.18 Sanofi
10.18.1 Sanofi Company Details
10.18.2 Sanofi Business Overview and Its Total Revenue
10.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.18.5 Sanofi Recent Development
13.19 Teva Pharmaceuticals Industries Ltd.
10.19.1 Teva Pharmaceuticals Industries Ltd. Company Details
10.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
10.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.19.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.19.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.20 Zavante Therapeutics, Inc.
10.20.1 Zavante Therapeutics, Inc. Company Details
10.20.2 Zavante Therapeutics, Inc. Business Overview and Its Total Revenue
10.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.20.5 Zavante Therapeutics, Inc. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Delafloxacin
1.4.3 Vancomycin
1.4.4 Ceftaroline Fosamil
1.4.5 Others
1.5 Market by Application
1.5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Cellulitis
1.5.3 Abscess
1.5.4 Surgical Wounds
1.5.5 Traumatic Wound
1.6 Coronavirus Disease 2019 (Covid-19): Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry
1.6.1.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Perspective (2015-2026)
2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Regions
2.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Market Size
3.1.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue (2015-2020)
3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio
3.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2019
3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players Head office and Area Served
3.4 Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
3.5 Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2021-2026)
5 ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in North America (2019-2020)
6.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
6.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in China (2019-2020)
8.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
8.4 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in India (2019-2020)
11.3 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
11.4 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2015-2020)
12.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Furiex Pharmaceuticals, Inc.
13.1.1 Furiex Pharmaceuticals, Inc. Company Details
13.1.2 Furiex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020))
13.1.5 Furiex Pharmaceuticals, Inc. Recent Development
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Details
13.2.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
13.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline plc Recent Development
13.3 Melinta Therapeutics, Inc.
13.3.1 Melinta Therapeutics, Inc. Company Details
13.3.2 Melinta Therapeutics, Inc. Business Overview and Its Total Revenue
13.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.3.5 Melinta Therapeutics, Inc. Recent Development
13.4 Debiopharm International S.A.
13.4.1 Debiopharm International S.A. Company Details
13.4.2 Debiopharm International S.A. Business Overview and Its Total Revenue
13.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.4.5 Debiopharm International S.A. Recent Development
13.5 MerLion Pharmaceuticals Pte Ltd.
13.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details
13.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview and Its Total Revenue
13.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
13.6 Durata Therapeutics, Inc.
13.6.1 Durata Therapeutics, Inc. Company Details
13.6.2 Durata Therapeutics, Inc. Business Overview and Its Total Revenue
13.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.6.5 Durata Therapeutics, Inc. Recent Development
13.7 Paratek Pharmaceuticals, Inc.
13.7.1 Paratek Pharmaceuticals, Inc. Company Details
13.7.2 Paratek Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.7.5 Paratek Pharmaceuticals, Inc. Recent Development
13.8 Cempra, Inc.
13.8.1 Cempra, Inc. Company Details
13.8.2 Cempra, Inc. Business Overview and Its Total Revenue
13.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.8.5 Cempra, Inc. Recent Development
13.9 Abbott Laboratories, Inc.
13.9.1 Abbott Laboratories, Inc. Company Details
13.9.2 Abbott Laboratories, Inc. Business Overview and Its Total Revenue
13.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.9.5 Abbott Laboratories, Inc. Recent Development
13.10 Actelion Pharmaceuticals Ltd.
13.10.1 Actelion Pharmaceuticals Ltd. Company Details
13.10.2 Actelion Pharmaceuticals Ltd. Business Overview and Its Total Revenue
13.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
13.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
13.10.5 Actelion Pharmaceuticals Ltd. Recent Development
13.11 Albany Molecular Research, Inc.
10.11.1 Albany Molecular Research, Inc. Company Details
10.11.2 Albany Molecular Research, Inc. Business Overview and Its Total Revenue
10.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.11.5 Albany Molecular Research, Inc. Recent Development
13.12 Allergan plc.
10.12.1 Allergan plc. Company Details
10.12.2 Allergan plc. Business Overview and Its Total Revenue
10.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.12.5 Allergan plc. Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview and Its Total Revenue
10.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 Bayer AG
10.14.1 Bayer AG Company Details
10.14.2 Bayer AG Business Overview and Its Total Revenue
10.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.14.5 Bayer AG Recent Development
13.15 Macrolide Pharmaceuticals, Inc.
10.15.1 Macrolide Pharmaceuticals, Inc. Company Details
10.15.2 Macrolide Pharmaceuticals, Inc. Business Overview and Its Total Revenue
10.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.15.5 Macrolide Pharmaceuticals, Inc. Recent Development
13.16 Merck & Co, Inc.
10.16.1 Merck & Co, Inc. Company Details
10.16.2 Merck & Co, Inc. Business Overview and Its Total Revenue
10.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.16.5 Merck & Co, Inc. Recent Development
13.17 Pfizer, Inc.
10.17.1 Pfizer, Inc. Company Details
10.17.2 Pfizer, Inc. Business Overview and Its Total Revenue
10.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.17.5 Pfizer, Inc. Recent Development
13.18 Sanofi
10.18.1 Sanofi Company Details
10.18.2 Sanofi Business Overview and Its Total Revenue
10.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.18.5 Sanofi Recent Development
13.19 Teva Pharmaceuticals Industries Ltd.
10.19.1 Teva Pharmaceuticals Industries Ltd. Company Details
10.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
10.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.19.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.19.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.20 Zavante Therapeutics, Inc.
10.20.1 Zavante Therapeutics, Inc. Company Details
10.20.2 Zavante Therapeutics, Inc. Business Overview and Its Total Revenue
10.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
10.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
10.20.5 Zavante Therapeutics, Inc. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
Table 3. Ranking of Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Delafloxacin
Table 6. Key Players of Vancomycin
Table 7. Key Players of Ceftaroline Fosamil
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players to Combat Covid-19 Impact
Table 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2015-2020)
Table 18. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players
Table 25. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players (2015-2020)
Table 27. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2019)
Table 28. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
Table 31. Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Type (2015-2020)
Table 35. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Application (2015-2020)
Table 37. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 41. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 43. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 47. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 49. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 53. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 55. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 59. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 61. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 65. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 71. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 73. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 77. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 81. Furiex Pharmaceuticals, Inc. Company Details
Table 82. Furiex Pharmaceuticals, Inc. Business Overview
Table 83. Furiex Pharmaceuticals, Inc. Product
Table 84. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 85. Furiex Pharmaceuticals, Inc. Recent Development
Table 86. GlaxoSmithKline plc Company Details
Table 87. GlaxoSmithKline plc Business Overview
Table 88. GlaxoSmithKline plc Product
Table 89. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline plc Recent Development
Table 91. Melinta Therapeutics, Inc. Company Details
Table 92. Melinta Therapeutics, Inc. Business Overview
Table 93. Melinta Therapeutics, Inc. Product
Table 94. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 95. Melinta Therapeutics, Inc. Recent Development
Table 96. Debiopharm International S.A. Company Details
Table 97. Debiopharm International S.A. Business Overview
Table 98. Debiopharm International S.A. Product
Table 99. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 100. Debiopharm International S.A. Recent Development
Table 101. MerLion Pharmaceuticals Pte Ltd. Company Details
Table 102. MerLion Pharmaceuticals Pte Ltd. Business Overview
Table 103. MerLion Pharmaceuticals Pte Ltd. Product
Table 104. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 105. MerLion Pharmaceuticals Pte Ltd. Recent Development
Table 106. Durata Therapeutics, Inc. Company Details
Table 107. Durata Therapeutics, Inc. Business Overview
Table 108. Durata Therapeutics, Inc. Product
Table 109. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 110. Durata Therapeutics, Inc. Recent Development
Table 111. Paratek Pharmaceuticals, Inc. Company Details
Table 112. Paratek Pharmaceuticals, Inc. Business Overview
Table 113. Paratek Pharmaceuticals, Inc. Product
Table 114. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 115. Paratek Pharmaceuticals, Inc. Recent Development
Table 116. Cempra, Inc. Business Overview
Table 117. Cempra, Inc. Product
Table 118. Cempra, Inc. Company Details
Table 119. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 120. Cempra, Inc. Recent Development
Table 121. Abbott Laboratories, Inc. Company Details
Table 122. Abbott Laboratories, Inc. Business Overview
Table 123. Abbott Laboratories, Inc. Product
Table 124. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 125. Abbott Laboratories, Inc. Recent Development
Table 126. Actelion Pharmaceuticals Ltd. Company Details
Table 127. Actelion Pharmaceuticals Ltd. Business Overview
Table 128. Actelion Pharmaceuticals Ltd. Product
Table 129. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 130. Actelion Pharmaceuticals Ltd. Recent Development
Table 131. Albany Molecular Research, Inc. Company Details
Table 132. Albany Molecular Research, Inc. Business Overview
Table 133. Albany Molecular Research, Inc. Product
Table 134. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 135. Albany Molecular Research, Inc. Recent Development
Table 136. Allergan plc. Company Details
Table 137. Allergan plc. Business Overview
Table 138. Allergan plc. Product
Table 139. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 140. Allergan plc. Recent Development
Table 141. AstraZeneca Company Details
Table 142. AstraZeneca Business Overview
Table 143. AstraZeneca Product
Table 144. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 145. AstraZeneca Recent Development
Table 146. Bayer AG Company Details
Table 147. Bayer AG Business Overview
Table 148. Bayer AG Product
Table 149. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 150. Bayer AG Recent Development
Table 151. Macrolide Pharmaceuticals, Inc. Company Details
Table 152. Macrolide Pharmaceuticals, Inc. Business Overview
Table 153. Macrolide Pharmaceuticals, Inc. Product
Table 154. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 155. Macrolide Pharmaceuticals, Inc. Recent Development
Table 156. Merck & Co, Inc. Company Details
Table 157. Merck & Co, Inc. Business Overview
Table 158. Merck & Co, Inc. Product
Table 159. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 160. Merck & Co, Inc. Recent Development
Table 161. Pfizer, Inc. Company Details
Table 162. Pfizer, Inc. Business Overview
Table 163. Pfizer, Inc. Product
Table 164. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 165. Pfizer, Inc. Recent Development
Table 166. Sanofi Company Details
Table 167. Sanofi Business Overview
Table 168. Sanofi Product
Table 169. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 170. Sanofi Recent Development
Table 171. Teva Pharmaceuticals Industries Ltd. Company Details
Table 172. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 173. Teva Pharmaceuticals Industries Ltd. Product
Table 174. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 175. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 176. Zavante Therapeutics, Inc. Company Details
Table 177. Zavante Therapeutics, Inc. Business Overview
Table 178. Zavante Therapeutics, Inc. Product
Table 179. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 180. Zavante Therapeutics, Inc. Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
Table 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
Table 3. Ranking of Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Delafloxacin
Table 6. Key Players of Vancomycin
Table 7. Key Players of Ceftaroline Fosamil
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players to Combat Covid-19 Impact
Table 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2015-2020)
Table 18. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players
Table 25. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players (2015-2020)
Table 27. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2019)
Table 28. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
Table 31. Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Type (2015-2020)
Table 35. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Application (2015-2020)
Table 37. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 41. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 43. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 47. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 49. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 53. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 55. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 59. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 61. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 65. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 71. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 73. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share (2019-2020)
Table 77. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2015-2020)
Table 81. Furiex Pharmaceuticals, Inc. Company Details
Table 82. Furiex Pharmaceuticals, Inc. Business Overview
Table 83. Furiex Pharmaceuticals, Inc. Product
Table 84. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 85. Furiex Pharmaceuticals, Inc. Recent Development
Table 86. GlaxoSmithKline plc Company Details
Table 87. GlaxoSmithKline plc Business Overview
Table 88. GlaxoSmithKline plc Product
Table 89. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline plc Recent Development
Table 91. Melinta Therapeutics, Inc. Company Details
Table 92. Melinta Therapeutics, Inc. Business Overview
Table 93. Melinta Therapeutics, Inc. Product
Table 94. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 95. Melinta Therapeutics, Inc. Recent Development
Table 96. Debiopharm International S.A. Company Details
Table 97. Debiopharm International S.A. Business Overview
Table 98. Debiopharm International S.A. Product
Table 99. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 100. Debiopharm International S.A. Recent Development
Table 101. MerLion Pharmaceuticals Pte Ltd. Company Details
Table 102. MerLion Pharmaceuticals Pte Ltd. Business Overview
Table 103. MerLion Pharmaceuticals Pte Ltd. Product
Table 104. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 105. MerLion Pharmaceuticals Pte Ltd. Recent Development
Table 106. Durata Therapeutics, Inc. Company Details
Table 107. Durata Therapeutics, Inc. Business Overview
Table 108. Durata Therapeutics, Inc. Product
Table 109. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 110. Durata Therapeutics, Inc. Recent Development
Table 111. Paratek Pharmaceuticals, Inc. Company Details
Table 112. Paratek Pharmaceuticals, Inc. Business Overview
Table 113. Paratek Pharmaceuticals, Inc. Product
Table 114. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 115. Paratek Pharmaceuticals, Inc. Recent Development
Table 116. Cempra, Inc. Business Overview
Table 117. Cempra, Inc. Product
Table 118. Cempra, Inc. Company Details
Table 119. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 120. Cempra, Inc. Recent Development
Table 121. Abbott Laboratories, Inc. Company Details
Table 122. Abbott Laboratories, Inc. Business Overview
Table 123. Abbott Laboratories, Inc. Product
Table 124. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 125. Abbott Laboratories, Inc. Recent Development
Table 126. Actelion Pharmaceuticals Ltd. Company Details
Table 127. Actelion Pharmaceuticals Ltd. Business Overview
Table 128. Actelion Pharmaceuticals Ltd. Product
Table 129. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 130. Actelion Pharmaceuticals Ltd. Recent Development
Table 131. Albany Molecular Research, Inc. Company Details
Table 132. Albany Molecular Research, Inc. Business Overview
Table 133. Albany Molecular Research, Inc. Product
Table 134. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 135. Albany Molecular Research, Inc. Recent Development
Table 136. Allergan plc. Company Details
Table 137. Allergan plc. Business Overview
Table 138. Allergan plc. Product
Table 139. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 140. Allergan plc. Recent Development
Table 141. AstraZeneca Company Details
Table 142. AstraZeneca Business Overview
Table 143. AstraZeneca Product
Table 144. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 145. AstraZeneca Recent Development
Table 146. Bayer AG Company Details
Table 147. Bayer AG Business Overview
Table 148. Bayer AG Product
Table 149. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 150. Bayer AG Recent Development
Table 151. Macrolide Pharmaceuticals, Inc. Company Details
Table 152. Macrolide Pharmaceuticals, Inc. Business Overview
Table 153. Macrolide Pharmaceuticals, Inc. Product
Table 154. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 155. Macrolide Pharmaceuticals, Inc. Recent Development
Table 156. Merck & Co, Inc. Company Details
Table 157. Merck & Co, Inc. Business Overview
Table 158. Merck & Co, Inc. Product
Table 159. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 160. Merck & Co, Inc. Recent Development
Table 161. Pfizer, Inc. Company Details
Table 162. Pfizer, Inc. Business Overview
Table 163. Pfizer, Inc. Product
Table 164. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 165. Pfizer, Inc. Recent Development
Table 166. Sanofi Company Details
Table 167. Sanofi Business Overview
Table 168. Sanofi Product
Table 169. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 170. Sanofi Recent Development
Table 171. Teva Pharmaceuticals Industries Ltd. Company Details
Table 172. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 173. Teva Pharmaceuticals Industries Ltd. Product
Table 174. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 175. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 176. Zavante Therapeutics, Inc. Company Details
Table 177. Zavante Therapeutics, Inc. Business Overview
Table 178. Zavante Therapeutics, Inc. Product
Table 179. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020) (Million US$)
Table 180. Zavante Therapeutics, Inc. Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Delafloxacin Features
Figure 3. Vancomycin Features
Figure 4. Ceftaroline Fosamil Features
Figure 5. Others Features
Figure 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Cellulitis Case Studies
Figure 8. Abscess Case Studies
Figure 9. Surgical Wounds Case Studies
Figure 10. Traumatic Wound Case Studies
Figure 11. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered
Figure 12. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players in 2019
Figure 17. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2019
Figure 19. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Furiex Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 28. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 30. Melinta Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 32. Debiopharm International S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 34. MerLion Pharmaceuticals Pte Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 36. Durata Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 38. Paratek Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 40. Cempra, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 42. Abbott Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 44. Actelion Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 46. Albany Molecular Research, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 48. Allergan plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 52. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 54. Macrolide Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 56. Merck & Co, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 58. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 62. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 64. Zavante Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Delafloxacin Features
Figure 3. Vancomycin Features
Figure 4. Ceftaroline Fosamil Features
Figure 5. Others Features
Figure 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Cellulitis Case Studies
Figure 8. Abscess Case Studies
Figure 9. Surgical Wounds Case Studies
Figure 10. Traumatic Wound Case Studies
Figure 11. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered
Figure 12. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players in 2019
Figure 17. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2019
Figure 19. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Furiex Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 28. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 30. Melinta Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 32. Debiopharm International S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 34. MerLion Pharmaceuticals Pte Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 36. Durata Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 38. Paratek Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 40. Cempra, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 42. Abbott Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 44. Actelion Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 46. Albany Molecular Research, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 48. Allergan plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 52. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 54. Macrolide Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 56. Merck & Co, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 58. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 62. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 64. Zavante Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
